Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
3.840
+0.100 (2.67%)
At close: Dec 5, 2025, 4:00 PM EST
3.770
-0.070 (-1.82%)
After-hours: Dec 5, 2025, 6:01 PM EST

Minerva Neurosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-14.031.44-30.01-32.11-49.911.94
Upgrade
Depreciation & Amortization
0.010.010.01-0.10.18
Upgrade
Other Amortization
-0.020.030.01--
Upgrade
Asset Writedown & Restructuring Costs
----15.2-
Upgrade
Loss (Gain) From Sale of Investments
------0.09
Upgrade
Stock-Based Compensation
1.121.331.974.115.229.7
Upgrade
Other Operating Activities
--22.028.287.414.52-
Upgrade
Change in Accounts Payable
0.27-0.20.84-0.880.86-1.32
Upgrade
Change in Unearned Revenue
------41.18
Upgrade
Change in Other Net Operating Assets
-1.56-0.124.1-3.18-0.6-3.06
Upgrade
Operating Cash Flow
-14.2-19.55-14.78-24.65-24.6-33.82
Upgrade
Capital Expenditures
----0.02--
Upgrade
Investment in Securities
-----24.53
Upgrade
Investing Cash Flow
----0.02-24.53
Upgrade
Issuance of Common Stock
--20--13.69
Upgrade
Other Financing Activities
-0.05--0.4-060-0.46
Upgrade
Financing Cash Flow
-0.05-19.6-06013.24
Upgrade
Net Cash Flow
-14.24-19.554.82-24.6635.43.94
Upgrade
Free Cash Flow
-14.2-19.55-14.78-24.66-24.6-33.82
Upgrade
Free Cash Flow Margin
------82.14%
Upgrade
Free Cash Flow Per Share
-1.88-2.58-2.27-4.62-4.61-6.61
Upgrade
Levered Free Cash Flow
-9.17-15.48-12.69-20.36-17.086.83
Upgrade
Unlevered Free Cash Flow
-9.17-12.63-7.51-15.73-13.136.83
Upgrade
Change in Working Capital
-1.29-0.324.94-4.060.26-45.56
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.